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Mast cells (MCs) mature locally, thus possessing tis-
sue-dependent phenotypes for their critical roles in
both protective immunity against pathogens and the
development of allergy or inflammation. We previ-
ously reported that MCs highly express P2X7, a re-
ceptor for extracellular ATP, in the colon but not in
the skin. The ATP-P2X7 pathway induces MC activa-
tion and consequently exacerbates the inflammation.
Here, we identified the mechanisms by which P2X7
expression on MCs is reduced by fibroblasts in the
skin, but not in theother tissues. The retinoic-acid-de-
grading enzyme Cyp26b1 is highly expressed in skin
fibroblasts, and its inhibition resulted in the upregula-
tion of P2X7 on MCs. We also noted the increased
expression of P2X7 on skin MCs and consequent
P2X7- and MC-dependent dermatitis (so-called reti-
noiddermatitis) in thepresenceof excessive amounts
of retinoic acid. These results demonstrate a unique
skin-barrier homeostatic network operating through
Cyp26b1-mediated inhibition of ATP-dependent MC
activation by fibroblasts.
INTRODUCTION
Mast cells (MCs) produce inflammatory mediators to initiate and
exacerbate inflammation (Gilfillan and Beaven, 2011; Tsai et al.,530 Immunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc.2011). Therefore, depletion or inhibition of activatedMCs attenu-
ates the inflammatory reactions (Feyerabend et al., 2011; Otsuka
et al., 2011). MCs are activated by various stimuli such as
allergen-immunoglobulin E (IgE) complex and high-affinity IgE re-
ceptor (FcεRI) pathway, and molecules released from necrotic
cells (e.g., IL-33) after tissue injury in various inflammatory condi-
tions (Lunderius-Andersson et al., 2012). Furthermore, previous
findings, including ours, suggest that extracellular ATP acts as
a danger signal to MCs and initiates inflammation (Kurashima
et al., 2012; Sudo et al., 1996). Extracellular ATP is released in
response to various stresses including shear, osmolality, oxida-
tive, and inflammatory one (Junger, 2011). Local ATP injection
into the skin induces ear swelling (Mizumoto et al., 2002). Further-
more, ATP amounts are increased in the extracellular compart-
ment in irritant contact dermatitis associatedwith zinc-deficiency
(Kawamura et al., 2012;Mizumoto et al., 2002). In addition to skin
inflammation, increased ATP concentrations are also found in
asthma, graft-versus-host disease, and inflammatory bowel dis-
ease (Idzko et al., 2007; Wilhelm et al., 2010; Kurashima et al.,
2012). To resolve inflammation, the extracellular ATP is degraded
by the ectonucleoside triphosphate diphosphohydrolase CD39
expressed on immune cells such as Langerhans cells (LCs) and
regulatory Tcells (Junger, 2011). Therefore, inflammation is exac-
erbated in CD39-deficient mice because of increased local ATP
concentration (Mizumoto et al., 2002).
As receptors for extracellular ATP, P2 purinoceptors
comprise P2X1 to P2X7 and act as ATP-gated ion channels
(Di Virgilio, 2007). P2X7 is involved in various inflammations
and thus inflammation associated with graft-versus-host dis-
ease and colonic inflammation are ameliorated by P2X7 inhibi-
tion (Kurashima et al., 2012; Wilhelm et al., 2010). In addition,
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Figure 1. Low P2X7 Expression on Skin
Mast Cells
(A) P2X7 expression on MCs in the colon, small
intestine (SI), lung, peritoneal cavity (PEC), and
skin was measured by flow cytometry. ‘‘Isotype’’
indicates isotype IgG2b staining as a negative
control. Data are representative of at least six in-
dependent experiments.
(B) Gene expression of P2rx7 in sorted MCs from
various tissues was examined by quantitative
RT-PCR. Data are means ± SEM (n = 4). *p < 0.05;
**p < 0.01.
(C) Production of MCP1 and TNF-a in culture
supernatant was determined after stimulation of
bone-marrow-derived MCs (BMMCs) or skin MCs
with 0.5 mM ATP. Data are shown as means ±
SEM (n = 3). **p < 0.01; n.s., not significant.
(D) IL-1b production was measured by ELISA after
sorted MCs from WT or P2rx7/ mice were
stimulated with LPS with or without ATP (n = 3).
**p < 0.01; n.s., not significant.
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Skin Fibroblasts Control Mast Cell Activationcathelicidin-derived peptide LL37 directly stimulates P2X7
and induces skin inflammation such as psoriasis and rosacea
(Elssner et al., 2004; Yamasaki et al., 2007). Despite such re-
searches, little is understood about the regulatory mechanisms
of P2X7 expression.
We previously generated an anti-P2X7 monoclonal antibody
and revealed that P2X7 is highly expressed on colonic MCs,
which is associated with the aggravation of intestinal inflamma-
tion (Kurashima et al., 2012). We simultaneously observed that
skin MCs have lower—or almost no—expression of P2X7
(Kurashima et al., 2012). Intriguingly, it was reported that exces-
sive production of IL-1b in skin MCs as a result of constitutive
activation of NOD-like receptor family, pyrin domain-containing
3 (one of the signal pathways of P2X7), causes skin inflammation
(Nakamura et al., 2012). These observations suggest that
ectopic expression and aberrant activation of P2X7 inMCsmight
elicit skin inflammation. Here, we identified the unique regulatory
function of skin fibroblasts in producing the retinoic acid (RA)-de-
grading enzyme Cyp26b1 to inhibit P2X7 expression on MCs for
maintaining the skin homeostasis. Furthermore, we provide evi-
dence that disruption of Cyp26b1-mediated regulatory function
of skin fibroblasts, together with commensal microbial stimula-
tion, induced the development of P2X7- and MC-mediated
severe dermatitis.
RESULTS
Low P2X7 Expression by Skin MCs Accounts for
Insensitivity to Extracellular ATP
We initially confirmed that skin c-kit+ FcεRIa+ cells were MCs by
their selective depletion by diphtheria toxin (DT) treatment of
MaS-TRECK mice where DT receptor (DTR) was specifically ex-Immunity 40, 530–5pressed on MCs (see Figure S1A avail-
able online) (Sawaguchi et al., 2012). In
our previous study, P2X7 is expressed
on MCs in the colon but low or undetect-
able in skin MCs (Kurashima et al., 2012).When we further compared P2X7 expression onMCs among co-
lon, small intestine, lung, peritoneal cavity (PEC), and skin, it was
lower on skin MCs than on MCs in the other tissues (Figure 1A).
To assess whether the lower P2X7 expression on skin MCs was
due to low expression at transcription or posttranscriptional
events, we performed RT-PCR and intracellular flow cytometry
analysis. Gene expression encoding P2X7 (P2rx7) was low on
skin MCs, but not on MCs from the other tissues (Figure 1B).
Consistently, the intracellular expression of P2X7 protein was
also low in skin MCs (Figure S1B).
MCs can be categorized into two types—connective tissue
and mucosal—in terms of protease phenotype. Connective-tis-
sue-type MCs are located mainly in the skin and PEC and ex-
press mast cell protease (Mcpt) 4 and 5 (Gurish and Austen,
2012). Mucosal-type MCs are located in the gastroenterological
mucosa and express Mcpt2 (Xing et al., 2011). Quantitative RT-
PCR (qRT-PCR) and gene-microarray analyses indicated that
even though the protease expression patterns were identical to
those in previous observations (Figure S1C), P2X7 expression
patterns were not applicable to the current two MC subtypes
(Figure S1D).
To examine the reactivity of skin MCs against extracellular
ATP, we stimulated themwith ATP andmeasured the production
of tumor necrosis factor alpha (TNF-a) andMCP1. In accordance
with the lack of P2X7 expression on skin MCs, production of
TNF-a and MCP1 upon ATP stimulation was detected in bone-
marrow-derived MCs (BMMCs), but not skin MCs (Figure 1C).
P2X7 plays a pivotal role in inflammasome activation along
with stimulation by bacterial components such as lipopolysac-
charide (LPS); these actions lead to interleukin-1b (IL-1b) pro-
duction (Di Virgilio, 2007). Thus, IL-1b production was noted
when PEC MCs from wild-type (WT) but not P2rx7/ mice41, April 17, 2014 ª2014 Elsevier Inc. 531
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Skin Fibroblasts Control Mast Cell Activationwere stimulated with both LPS and ATP. In contrast, skin MCs
from both WT and P2rx7/ mice did not produce IL-1b
(Figure 1D).
Skin Environment-Mediated Downregulation of P2X7
Expression Is Independent of Commensal Microbiota
and Immune Cells
MC progenitors differentiate into mature MCs in the local tissues
(Gurish and Austen, 2012; Xing et al., 2011). We therefore
considered that P2X7 expression would be affected by skin envi-
ronment. To test this possibility, we transferred P2X7-expressing
(WT) BMMCs directly into the skin of MC-deficient KitW-sh/W-sh
mice. P2X7 expression on transferred MCs was gradually
decreased to identical expression to those of skin resident
MCs in WT mice within 10 days after adoptive transfer (Figures
2A and 2B). Furthermore, long-term reconstitution of MCs via
the intravenous and intraperitoneal routes in KitW-sh/W-sh mice
led to successful reconstitution of P2X7-expressing MCs in the
PEC and colon, whereas MCs in the skin showed low P2X7
expression (Figure S2A; data not shown) (Kurashima et al.,
2012). These results indicated that P2X7 expression on MCs
was reversible which was directly and negatively regulated by
the skin environment.
It was recently shown that commensal microbiota stimulate
immune responses in the skin (Naik et al., 2012), allowing us to
compare P2X7 expression in specific-pathogen-free (SPF) and
germ-free (GF) mice and in mice lacking MyD88, an adaptor
molecule of an innate sensor for bacterial components (e.g.,
toll-like receptors [TLRs]). The low P2X7 expression on skin
MCs was maintained in these mice (Figures 2C and D), suggest-
ing that commensal microbiota did not directly influence P2X7
expression on skin MCs.
Various unique immune cells, such as gd T cells and LCs, are
important for maintaining skin homeostasis (Di Meglio et al.,
2011). To examine the contribution of immune cells to the reduc-
tion of P2X7 on skin MCs, we analyzed mice lacking T cells
(Tcrb/TCRd/), B cells (Ighm/), or both (Rag1/). Identi-
cally low P2X7 expression was seen on skin MCs of these
mice (Figures 2C and 2E). To further explore the involvement of
other immune cells, we analyzed DT-treated Itgax-DTR mice
(Jung et al., 2002) and Id2/ mice (Hacker et al., 2003), which
lack dendritic cells (DCs) and LCs, respectively. No change of
P2X7 expression on skin MCs was noted in the absence of
DCs or LCs (Figures 2C and 2F). Also, the P2X7 expression in
the colon MCs was comparable among these gene-deficient
and WT mice (data not shown). Thus, T and B cells, DCs, and
LCs were dispensable for the downregulation of P2X7 expres-
sion on skin MCs.
The skin possesses inhibitory cytokines, vitamins, and lipid
mediators (Biggs et al., 2010; Schirmer et al., 2010). For instance,
vitamin D3 and IL-10 play regulatory roles in skin inflammation
(Biggs et al., 2010). Although IL-10 receptor expression on
MCs was slightly higher in skin than in colon (Figure 2G), no
changes of P2X7 expression were noted on MCs supplemented
with 1a,25(OH)2D3 (an active metabolite of vitamin D3) or in
Il10/ mice (Figure S2B; Figure 2H). We also assessed the
involvement of prostaglandin E2 (PGE2), another candidate for
control of skin MC functions (Gilfillan and Beaven, 2011). P2X7
expression on BMMCs was not altered when they were treated532 Immunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc.with PGE2, indomethacin, or pertussis toxin, an inhibitor of G
protein-coupled receptor pathway including PGE2 receptors
(Figure S2C). These results indicated that these mediators
were redundant in regulating P2X7 expression on MCs.
Skin FibroblastsDownregulate P2X7Expression onMCs
It has been suggested that communication of MCs with stromal
cells or fibroblasts induces optimal and tissue-dependent matu-
ration. Indeed, coculture of skin 3T3 fibroblasts with immature
MCs modulates the MC phenotypes, such as the expression
of proteases and adhesion molecules (Takano et al., 2008). We
confirmed that skin MCs were localized with fibroblasts in vivo
(Figure S3A). To test the involvement of fibroblasts in the regula-
tion of P2X7 expression, we isolated fibroblasts or stromal
cells from the skin, lung, small intestine, and colon. We
confirmed the morphological characteristics of tissue-derived
fibroblasts or stromal cells (e.g., bipolar or multipolar) and their
elongated shape with adherent growth together with expression
of ER-TR7, a stromal cell pan-marker (Figures S3B and S3C).
Coculture of BMMCs with colon stromal cells induced the
expression of Mcpt1 and Mcpt2, indicative of mucosal-type
MCs; whereas skin fibroblasts induced Mcpt4 expression in
cocultured BMMCs, which is indicative of connective tissue
MCs (Figure S3D). In contrast, the expression of FcεRIa on
MCs was not changed in these conditions (Figure S3D). In addi-
tion, morphological and biochemical analyses revealed that
skin fibroblasts regulated the expression of secretory granule
components, such as heparin and chondroitin sulfate, in the
cocultured MCs (Figure S3E); this behavior is characteristics
of connective-tissue-typeMCs (Gurish and Austen, 2012). These
results indicated that coculture with stromal cells or fibroblasts
induced the terminally differentiated and local-environment-
adjusted MCs.
Under these experimental conditions, skin fibroblasts in-
hibited the P2X7 expression on cocultured BMMCs (Figures 3A
and 3B). However, stromal cells from the colon and small intes-
tine did not suppress their P2X7 expression (Figures 3A and 3B).
In the case of coculture with lung-derived fibroblasts, P2X7
expression was partially suppressed, but the suppression was
weaker than that with skin fibroblasts (Figures 3A and 3B). Inter-
estingly, inhibition of P2X7 expression still occurred when both
cell types were separately cultured in a transwell culture system
(Figure 3C), suggesting that secretory factors from the skin fibro-
blasts are capable of reducing the P2X7 expression on MCs.
Because MCs were differentiated from MC progenitors (Gurish
and Austen, 2012), we cocultured BM cells containing MC pro-
genitors with either skin fibroblasts or colon stromal cells for 2
to 3 weeks. P2X7 expression on newly differentiated MCs was
detected in the presence of colonic stromal cells, whereas their
P2X7 expression was decreased in the presence of skin fibro-
blasts (Figure 3D). Furthermore, P2X7 expression recovered
when the skin fibroblasts were removed from the culture or re-
placed with colon stromal cells (Figures 3E and 3F). Consistent
with our findings (Figure 1), the expression of mRNA encoding
P2rx7was accordingly changed (Figure 3G), and BMMCs cocul-
tured with skin fibroblasts did not produce MCP1 and TNF-a
upon extracellular ATP stimulation (Figure 3H). Like P2X7
expression, gene expressions of Mcpt1, Mcpt2, and Mcpt4
and the production of heparin and chondroitin sulfate induced
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Figure 2. Skin Environment Regulates P2X7 Expression
(A and B) Flow cytometric analysis was performed to measure P2X7 expression on skin MCs from WT or KitW-sh/W-sh mice receiving adaptive transfer of P2X7+
bone-marrow-derived MCs (BMMCs) (A) and mean fluorescence intensity (MFI) was examined (B). Data are means ± SEM. *p < 0.05 (n = 3); **p < 0.01; n.s., not
significant.
(C–F) MFI of P2X7 expression on skinMCs from variousmice were examined by flow cytometry (C). Data aremeans ± SEM (n = 3 to 8). (D-F) P2X7 expression was
measured by flow cytometry on skin MCs from specific-pathogen free (SPF), germ free (GF), andMyd88/mice (D), and Tcrb/Tcrd/, Ighm/, and Rag1/
mice (E), diphtheria-toxin-treated Itgax-DTR transgenic, Id2+/+, and Id2/ mice (F). Control staining with isotype control is shown as gray.
(G) IL-10 receptor (IL-10R) expression on MCs from skin and colon was analyzed by flow cytometry.
(H) P2X7 expression on skin MCs was measured in WT and Il10/mice. Control staining with isotype control is shown as gray. All data are representative of at
least three independent experiments.
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Figure 3. Skin Fibroblasts Regulate P2X7 Expression on Mast Cells
(A) BMMCs were cultured with or without skin fibroblasts, lung fibroblasts, or small intestine (SI) or colon stromal cells and stained for P2X7. Control staining with
rat IgG2b is shown as gray.
(B) Mean fluorescence intensity (MFI) of P2X7 expression is shown. Data are means ± SEM. **p < 0.01, one-way ANOVA and Tukey’s method (n = 5 to 8).
(C) BMMCs and colon stromal cells or skin fibroblasts were separately cultured in the transwells for 3 weeks. P2X7 expression BMMCs was measured by flow
cytometry. Control staining with rat IgG2b is shown as gray. Data are means ± SEM (n = 6). **p < 0.01.
(D) Bonemarrow cells were cultured with or without skin fibroblasts or colon stromal cells, together with IL-3 and stem cell factor for 3 weeks. Expression of c-kit,
FcεR1a, and P2X7 was measured by flow cytometry. Control staining with rat IgG2b is shown as gray.
(E and F) Bone-marrow cells were cocultured with skin fibroblasts for 3 weeks and then cultured with or without skin fibroblasts or colon stromal cells for an
additional 4 days. P2X7 was measured by flow cytometry (E) and MFI of P2X7 expression is shown (F). Data are means ± SEM. **p < 0.01, (n = 4 to 6). All data are
representative of at least three independent experiments.
(G) BMMCs were sorted after coculture with skin fibroblasts and colon stromal cells, and P2rx7 expression was examined by quantitative RT-PCR. Relative
expression was normalized against Gapdh. Data are means ± SEM. **p < 0.01, *p < 0.05 (n = 4).
(H) BMMCs were sorted after coculture with skin fibroblasts and colon stromal cells and then stimulated with 0.5 mM ATP. Production of MCP1 and TNF-a in
culture supernatant was determined. Black bars, no treatment; white bars, ATP stimulation. Data are means ± SEM. *p < 0.05, **p < 0.01, n.s. not significant.
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Skin Fibroblasts Control Mast Cell Activationby coculture with skin fibroblasts were reversed by removal of
skin fibroblasts or replacement with colon stromal cells (Figures
S3E and S3F). These results suggest that skin fibroblasts play a
pivotal role in the downregulation of P2X7 expression on MCs,
leading to the blockade of their reactivity to extracellular ATP.
Cyp26b1 Plays a Critical Role in Negative Regulation of
P2X7 Expression on MCs
Gene expression was compared between skin fibroblasts and
colon stromal cells, as an example of P2X7-inhibitor and nonin-
hibitor cells, respectively. Gene microarray analysis identified534 Immunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc.several genes expressed more highly in skin fibroblasts than in
colonic stromal cells, including gene encoding the retinoic-acid
(RA)-degrading enzymes Cyp26a1 and Cyp26b1 (Figure 4A).
Quantitative RT-PCR analysis confirmed the higher expression
ofCyp26b1 in the skin fibroblasts than colonic stromal cells (Fig-
ure 4B), whereas vimentin, a stromal cell pan-marker, was iden-
tically expressed in both cell types (Figure 4C). It was reported
that Cyp26b1 is involved in skin homeostasis and thus increases
in RA concentrations through disruption of Cyp26b1 cause ab-
normalities in embryonic skin barrier formation (Okano et al.,
2012). In addition, in vitro culture of CD8+ T cells with RA induces
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Figure 4. Critical Role of Cyp26b1 in Regulating P2X7 Expression on Mast Cells
(A) Gene microarray analysis was performed to compare the gene expression between skin fibroblasts and colon stromal cells; representative genes are shown.
(B) Gene expression of Cyp26 families was examined by quantitative RT-PCR. Gene expression relative to Gapdh is shown. Data are means ± SEM. *p <
0.05 (n = 4).
(C) Vimentin expression on skin fibroblasts and colon stromal cells was examined by quantitative RT-PCR (qRT-PCR). Relative expressions were normalized
against Gapdh. Data are means ± SEM (n = 4). n.s., not significant.
(D and E) BMMCs were treated with 50 nM of retinoic acid (RA) for 6 days. The expression of P2X7 (D) andMcp1,Mcp2,Mcp4 and FcerIa (E) was then examined
by flow cytometry and qRT-PCR, respectively. Data are means ± SEM (n = 4). *p < 0.05.
(F) BMMCs were cocultured with skin fibroblasts or colon stromal cells, with or without RA, LE540, or liarozole and stained for P2X7. Control staining with rat
IgG2b is shown as gray. Data are representative of at least three independent experiments.
(G) MFI of P2X7 expression was shown (n = 3 to 6). Data are means ± SEM. **p < 0.01.
(H) P2rx7 expression on cocultured BMMCs was examined by qRT-PCR. Data are means ± SEM (n = 4). **p < 0.01.
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Skin Fibroblasts Control Mast Cell ActivationP2X7 expression (Heiss et al., 2008). Therefore, it is possible
that Cyp26b1-mediated control of RA concentrations by skin
fibroblasts regulates P2X7 expression on MCs. To test this hy-
pothesis, we examined the P2X7 expression after adding RA to
BMMCs. P2X7 expression increased in the presence of RA
without affecting gene expression of Mcpt1, Mcpt2, and Mcpt4
(Figures 4D and 4E). Similarly, adding RA to BMMCs in the pres-
ence of skin fibroblasts also increased the P2X7 expression (Fig-
ures 4F and 4G). Reciprocally, LE540, an inhibitor of retinoid X
receptor and retinoid A receptor, suppressed the P2X7 expres-
sion on MCs cocultured with colon stromal cells (Figures 4F
and 4G). In addition, in vitro treatment of skin fibroblasts with liar-
ozole, a Cyp26b1 inhibitor, augmented P2X7 expression onMCs(Figures 4F–4H). These data demonstrate the critical roles of skin
fibroblasts in modulation of P2X7 expression on MCs via the RA
metabolic enzyme Cyp26b1.
Aberrant P2X7 Expression on MCs Induces Skin
Inflammation, and Its Inhibition Ameliorates Disease
Development
Retinoid and its metabolites play important roles in both pro- and
anti-inflammatory responses (Fisher and Voorhees, 1996). Reti-
noids display key physiological roles in maintaining skin homeo-
stasis, and dysregulation of retinoid signaling is found in various
skin diseases. Indeed, topical treatment with retinoids causes
epidermal hyperplasia and thickening of the differentiatedImmunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc. 535
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Figure 5. Aberrant P2X7 Expression in Mast Cells Induces Retinoid Dermatitis
(A) Hematoxylin and eosin (H&E) staining of skin frommice treated with vehicle or RAwith or without liarozole (liaro) for 2 weeks. Data are representative of at least
three independent experiments. Scale bars represent 100 mm.
(B) Thickness of ear was measured. Data are means ± SEM. **p < 0.01 (n = 4).
(C) Severity of inflammation was scored. Data are means ± SEM. *p < 0.05 (n = 4).
(D) Expression of P2X7 on skin MCs in RA- or vehicle-treated mice was examined by flow cytometry analysis.
(E) Mice (WT; diphtheria toxin-treated MaS-TRECK, MaS; diphtheria toxin-treated BaS-TECK, BaS; and nude; nu/nu) were treated with RA for 8 weeks and ear
thickness was measured (n = 6 to 24).
(F) Severity of inflammation was scored (n = 3 to 4) (means ± SEM. *p < 0.05, **p < 0.01, one-way ANOVA and Tukey’s method).
(G) Representative H&E staining of ear are shown. Scale bars represent 100 mm.
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Skin Fibroblasts Control Mast Cell Activationsuprabasal layers, eventually leading to retinoid dermatitis
(Fisher and Voorhees, 1996; Garcı´a-Serrano et al., 2011). Addi-
tionally, skin irritation occurs with retinoid treatment (Varani
et al., 2003). High-dose oral administration of RA to pregnant
mice causes skin inflammation in the fetus (Okano et al., 2012).
These findings led to a hypothesis that P2X7 expression on
skin MCs induced by high concentration of RA might be of rele-
vance to skin irritation or retinoid dermatitis.
To test this hypothesis, mice were orally inoculated with 0.4%
RA twice a week for several weeks. These RA-treated mice
showed skin irritation and hypertrophy when compared with
vehicle-treated mice (Figures 5A–5C; Figure S4A). Histological
analysis showed that RA treatment caused dermatitis associated
with the accumulation of inflammatory cells andMCs (Figures 5A;
Figure S4B–S4E). Importantly, P2X7 expression in skin MCs in
RA-treated mice was augmented compared with that in vehicle-
treatedmice (Figure 5D).Moreover, inhibition ofCyp26b1-depen-
dent RA metabolism by the treatment with liarozole exacerbated
the skin inflammation comparedwith RA treatment alone (Figures536 Immunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc.5A–5C; Figure S4B). These results indicated that Cyp26b1
counteract the onset of RA-induced dermatitis. Furthermore,
RA-induced dermatitis was ameliorated in P2rx7/- and MC-
deficientmice, but not in basophil-deficientmice (Figures5E–5G).
We confirmed a previous report (Hall et al., 2011) that RA in-
duces the differentiation of both T helper 17 (Th17) and regulatory
T cells (Figure S4F). RA treatment also slightly induced P2X7
expression on skin T cells (Figure S4G). Therefore, to evaluate
the possible involvement of T cells in the induction of RA-induced
dermatitis,weanalyzedTcell-deficientnude (nu/nu)mice (Figures
5E–5G).We observed ear swelling accompanied by inflammation
in nu/nu mice (Figures 5E–5G), indicating that, even though RA
treatment affected the P2X7 expression in both T cells and
MCs,MCsplay central roles in the induction of retinoid dermatitis.
To examine the expression of P2X7 ligands in retinoid derma-
titis, we next measured the production of extracellular ATP—a
major ligand of P2X7—in mice with retinoid dermatitis or mice
receiving skin scratch as a control (Kawamura et al., 2012). We
detected elevated amounts of ATP in the skin of mice with
A B C
D
E F G
Figure 6. Skin Commensal Bacteria Contribute to P2X7-Medaited Retinoid Dermatitis
(A) ATP concentrations released from skin tissues were measured (means ± SEM. *p < 0.05; **p < 0.01).
(B) The numbers of monocytes and macrophages (Mono-Mac) and neutrophils (Neu) in the skin after RA-treatment were quantified (black bars, WT; gray bars;
P2x7/; white bars, diphtheria toxin-treated MaS-TRECK mice) (means ± SEM. *p < 0.05; **p < 0.01).
(C) TLR2 expression was examined in MCs, CD11b+ Mono-Mac, and gd T cells. Control staining with isotype control antibody is shown as gray.
(D) Tlr2/, Myd88/, and Tlr4/, specific-pathogen-free (SPF), germ-free (GF), and antibiotic-treated mice were treated with retinoic acid for 8 weeks;
representative hematoxylin and eosin staining of ear are shown. Data are representative of at least three independent experiments. Scale bars represent 100 mm.
(E) Severity of inflammation was scored (n = 4 to 6). Data are means ± SEM. **p < 0.01; one-way ANOVA and Tukey’s method.
(F) Cathelicidin (green) expression was measured by confocal microscopy. Scale bars represent 100 mm.
(G) Kallikrein (KLK) 5 (n = 9) and 7 (n = 4) expression was examined by qRT-PCR. Data are means ± SEM. *p < 0.05.
Immunity
Skin Fibroblasts Control Mast Cell Activationretinoid dermatitis as scratched skin (Figure 6A). In addition,
degradation of extracellular ATP by local administration of
apyrase suppressed at least partly the severity of retinoid derma-
titis (Figures S5A–S5C). The ATP-P2X7 pathway leads to the pro-
duction of lipid mediators (e.g., leukotriene B4) and chemokines
(e.g., MCP1, CCL7, and CXCL2) from MCs to recruit inflamma-
tory cells such as monocytes and neutrophils (Kurashima et al.,
2012). We found that CD11b+ monocytes and macrophages
and Gr-1+ neutrophils were increased in the skin of mice treated
with RA, but their abundance was lower in RA-treated mice
lacking P2X7 or MCs (Figure 6B). These results suggest that
increased ATP production in the RA-treated skin caused P2X7-
and MC-dependent skin inflammation.
P2X7-Mediated Retinoid Dermatitis Requires Innate
Immune Signaling
External stimuli—especially antimicrobial signaling—can pro-
voke or inhibit skin inflammation (Jin et al., 2009). We foundthat TLR2 was highly expressed by the accumulated cells (e.g.,
monocytes and macrophages) but relatively low in MCs and gd
T cells (Figure 6C). To determine whether microbial stimulation
via TLR2 participated in the induction of retinoid dermatitis,
Tlr2/ and Myd88/ mice were inoculated with a high dose
of RA. Thosemice had onlyminor incidence of retinoid dermatitis
after 8 weeks of RA inoculation, whereas identically treated
Tlr4/ mice had typical signs of retinoid dermatitis (Figures 6D
and 6E). These results suggest that signaling from TLR2 contrib-
utes to the development of retinoid dermatitis. It remains unclear
whether TLR2 signaling is mediated by microbial components,
because other endogenous ligands, such as hyaluronan frag-
ments, biglycan, and serum amyloid A, also activate TLR2
(Erridge, 2010). Therefore, to determine the requirement for
TLR2 ligands derived from skin microbiota, we induced retinoid
dermatitis in GF mice. In addition, we used mice receiving anti-
biotics orally because, unlike GF mice, which were free from
both gut and skin microbiota, oral antibiotic administration rarelyImmunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc. 537
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(Naik et al., 2012). Whole-mount fluorescent in situ hybridization
(FISH) analysis with EUB338 (a probe for most bacterial species)
confirmed the presence of skin bacteria in antibiotic-treated
mice, but not in GF mice (Figure S5D). When these two groups
of mice were subjected to retinoid dermatitis, inflammatory signs
were found in the antibiotic-treated mice, but not GF mice (Fig-
ures 6D and 6E). These findings suggest that recruitment and
activation of TLR2+ monocytes andmacrophages by skin micro-
biota are important for the aggravation of retinoid dermatitis.
Not only ATP but also the cathelicidin-derived peptide LL37
directly activates P2X7 (Elssner et al., 2004). Moreover, bacterial
components such as lipoteichoic acid, a ligand of TLR2, induce
cathelicidin production (Yamasaki et al., 2007). Indeed, we found
that expression of gene encoding cathelicidin were low in GF
mice subjected to retinoid dermatitis induction, but they were
unaltered in antibiotic-treated mice with retinoid dermatitis,
compared with SPFmice (Figure 6F). In addition, in vitro analysis
revealed that inflammatory monocytes increased the extracel-
lular ATP production and cathelicidin expression via TLR2-
dependent manner (Figures S5E and S5F). Kallikrein (KLK) 5
and 7 are required to process cathelicidin to produce LL37 in
the skin (Morizane et al., 2010). We found that RA treatment up-
regulated the expression of both Klk5 and Klk7 in the area of reti-
noid dermatitis (Figure 6G). Furthermore, another in vitro analysis
indicated thatCxcl1 andCxcl2 expression was increased inMCs
when they were cocultured with monocytes activated via TLR2
(Figure S5G). These observations indicated that cross-commu-
nication between skinmicrobiota- and TLR2-dependent produc-
tion of P2X7 ligands such as ATP and LL37 from inflammatory
monocytes and the activation of MCs via P2X7 is critical for
the development of retinoid dermatitis.
DISCUSSION
Skin and mucosa possesses immunologically unique regulatory
systems that create balanced homeostatic conditions in the face
of the harsh outside environment. It was suggested that tissue
environmental factors regulate locally unique MC phenotypes
(Xing et al., 2011). As protease expression patterns on MCs
(Xing et al., 2011), our previous findings suggested that P2X7
expression on MCs differs between the skin and intestine (Kura-
shima et al., 2012). Here, we found a function of skin fibroblasts
in reducing the P2X7 expression onMCs through themetabolism
of RA. This pathway creates unique niches for regulating the
homeostatic network of the skin-surface barrier by inhibiting
excessive ATP-mediated activation of MCs. We also proposed
the possible involvement of LL37 as another ligand of P2X7 in
skin inflammation. These observations reveal the unique tis-
sue-dependent immune regulation mediated by structural cells
such as stromal cells and fibroblasts to create homeostasis at
the skin-surface barrier. Breakdown of this system leads to the
development of inflammation such as retinoid dermatitis.
Activation of MCs is tightly regulated by multiple receptors.
For instance, elevated expression of IL-33 from epidermal kera-
tinocytes and dermal fibroblasts as a result of sun exposure
induces MC activation and hence skin inflammation (Lunder-
ius-Andersson et al., 2012). Simultaneously, various inhibitory
receptors, such as leukocyte monoimmunoglobulin-like recep-538 Immunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc.tor 3 and paired immunoglobulin-like receptor B, are typically ex-
pressed on MCs (Izawa et al., 2012; Masuda et al., 2007). Along
with the expression of these inhibitory receptors, regulation of
the expression of activation-type receptors such as P2X7 might
be important for inhibiting the abnormal activation of MCs under
tissue-specific environment, for example at sites where ligands
(e.g., ATP and LL37) are constantly or easily produced. Our re-
sults showed that TLR2-mediated activation was involved in
extracellular ATP release and simultaneous enhancement of
LL37 production by monocytes or macrophages. Furthermore,
MCs produced ATP via the actions of ATP synthase and adeny-
late kinase (Kurashima et al., 2012). Thus, extracellular ATP is
released from a various sources at millimolar concentration,
which are sufficient for P2X7-mediated MC activation at the
site of skin inflammation (Takahashi et al., 2013). Therefore, the
balanced and optimal expression of activation and inhibitory re-
ceptors, as well as ligand production, is required to maintain ho-
meostasis, which was tissue dependent. From this perspective,
our findings provide evidence for the presence and mechanism
of skin-specific negative regulation of ATP-mediated MC activa-
tion via the downregulation of P2X7.
RA has been used clinically to normalize skin homeostasis
in patients with acne or psoriasis (Geria and Scheinfeld, 2008).
However, topical application of excessive amounts of RA accel-
erates skin inflammation (Fisher and Voorhees, 1996). Treatment
with excessive amounts of 9-cis RA causes epidermal prolifera-
tion and increased skin thickness in mice (Garcı´a-Serrano et al.,
2011). Furthermore, Cyp26b1 deficiency in keratinocytes and
fibroblasts causes skin barrier disruption and inflammation in
mice (Okano et al., 2012). Our study indicated the importance
of RA-mediated upregulation of P2X7 on MCs in the develop-
ment of skin inflammation. Liarozole inhibits RA metabolism
with targeting not only Cyp26b1 but other P450 enzymes; thus,
off-target effects of liarozole could not be negligible (De Coster
et al., 1996). Our data indicated the highest expression of
Cyp26b1 in skin fibroblasts; these data, plus those from the
studies mentioned above, reflect the important aspects and ki-
netics of the skin fibroblast-Cyp26b1-mediated regulatory and
inhibitory system for creating and maintaining a physiologically
optimized skin-surface barrier system.
Mcpt expression is reversibly regulated by the tissue environ-
ment (Xing et al., 2011). Our data indicate that RA does not
regulate Mcpt expression, suggesting that the soluble signals
emanating from stromal cells and fibroblasts for MC differentia-
tion and for downregulation of P2X7 expressions differ from each
other. Our current findings also revealed that coculture with
lung fibroblasts partially reduced P2X7 expression in BMMCs.
This effect on P2X7 expression was weaker than that of skin fi-
broblasts; moreover, P2X7 suppressive capacity was correlated
with reduced expression of Cyp26b1 (data not shown). Because
concentrations of extracellular ATP were high in respiratory
inflammation and lung MCs in vivo expressed high P2X7 (Idzko
et al., 2007), reducing P2X7 expression on MCs by enhancing
Cyp26b1 expression in fibroblasts in the lung would be a thera-
peutic strategy for respiratory disorders.
MCs are involved in various skin inflammation, such as psori-
asis, atopic dermatitis, and alopecia areata (Cetin et al., 2009;
Gilfillan and Beaven, 2011; Otsuka et al., 2011). In this context,
high vitamin A concentration in serum is associated with a risk
Immunity
Skin Fibroblasts Control Mast Cell Activationof atopic dermatitis (Kull et al., 2006). In addition, it was recently
reported that dietary vitamin A is involved in aggravating chronic
inflammatory status in alopecia both inmice and human (Duncan
et al., 2013). In mice with alopecia areata, RA synthesis is
increased and simultaneously RA degradation is decreased,
thus resulting in excess concentrations of RA at the site of skin
inflammation (Duncan et al., 2013). Indeed, P2X7+ MCs are
accumulated at the site of alopecia in human (data not shown).
These results imply that dysregulation of P2X7 expression on
MCs occurs in particular skin inflammation associated with
disruption and interruption of RA metabolism. Therefore, it is
possible that RA-induced P2X7–MC cascades are also involved
in the RA-related skin inflammation.
Skin-resident bacteria play an autonomous role in controlling
the local inflammatory milieu by modulating the function of skin-
resident T cells (Naik et al., 2012). Functional TLRs are
expressed on MCs (Matsushima et al., 2004; Sandig and Bul-
fone-Paus, 2012). In addition, cathelicidin expression on MCs is
induced by the activation of TLR2 by lipoteichoic acid produced
by commensal bacteria. Indeed, TLR2 is highly expressed on
BMMCs (Wang et al., 2012). Therefore, it is possible that P2X7
and TLR2 dual pathways affect the skin MC-induced production
of inflammatory mediators. However, our experiments with three
different clones (6C2,mT2.7, andmT2.5) of anti-TLR2monoclonal
antibodies revealed that TLR2 was poorly expressed on the sur-
faces of skin MCs. Indeed, reconstitution of TLR2-deficient MCs
to the MC-deficient mice showed retinoid dermatitis after RA-
treatment (data not shown). In contrast, CD11b+ monocytes
and macrophages in the skin highly expressed TLR2, indicating
that skin-microbiota-mediated signaling stimulates accumulation
and activation of inflammatory cells in the skin; this might initiate
disruption of skin homeostasis, including the skin fibroblast-
Cyp26b1-mediated downregulation system of P2X7-dependent
MC activation. In addition, recruitment or activation of the
TLR2-expressing inflammatory cells is led by chemokines (e.g.,
MCP1) or lipid mediators (e.g., leukotrienes) released upon MC
activation and the induction of inflammatory responses by ATP
release. MCs also directly regulate DC activation in the skin;
indeed, maturation and migration of DCs are regulated by
TNF-a and ICAM1 on MCs; thus, MC-DC direct interaction could
also affect the pathogenesis of skin inflammation (Otsuka et al.,
2011). Our in vitro observation revealed that TLR2+ inflammatory
cells directly enhanced CXCL1 and CXCL2 expression in MCs,
which potentially led to the neutrophil recruitment into the inflam-
matory site. These results implied the existence of the inflamma-
tory loop among various immune cells including MCs.
These findings collectively reveal that MCs in various tissues
help to create tissue-specific local homeostasis operatedby indi-
vidual structural cells (e.g., fibroblasts). Cyp26b1-expressing
skin fibroblasts thus play a central role in homeostatic P2X7
downregulation on skin MCs, leading to the suppression of
ATP-induced abnormal activation. When the skin homeostatic
pathway is sporadically interrupted, such as in hypervitaminosis
A, skin bacterial stimulation triggers inflammation via the TLR2-
mediated pathway. Our additional understanding of the molecu-
lar andcellular basesof the functionsandphenotypesof localized
MCs and their surrounding structural cells (e.g., fibroblasts and
stromal cells) will facilitate the discovery of innovative and bene-
ficial targets for the control of tissue-specific inflammation.EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Balb/c, GF, and nu/nu/ mice were purchased from Japan CLEA.
Rag1/, Tcrb/, Tcrd/, Ighm/, P2rx7/, and Itgax-DTR mice were
obtained from Jackson Laboratory. Tlr2/, Tlr4/, andMyd88/ mice were
obtained from Dr. S. Akira (Osaka University). Id2/ mice were generated as
previously described (Yokota et al., 1999). KitW-sh/W-sh mice were obtained
from Dr. H. Suto (Juntendo University). MaS-TRECK and BaS-TRECK mice
were established as previously reported (Sawaguchi et al., 2012). All mice
weremaintainedunderSPForGFconditions at theExperimental Animal Facility
of the InstituteofMedical Science, theUniversityof Tokyo.All experimentswere
approved by the Animal Care and Use Committee of the University of Tokyo.
In Vivo Treatment
To remove DCs, we intraperitoneally treated Itgax-DTR mice with DT (500 ng,
Sigma-Aldrich) (Jung et al., 2002). To deplete MCs and basophils, we injected
MaS-TRECK and BaS-TRECK mice intraperitoneally with 250 ng DT for 5
consecutive days and then with 150 ng DT every other day (Sawaguchi et al.,
2012). Mice were orally inoculated with 0.4% RA (Sigma-Aldrich) in corn oil
(Wako) twiceaweek.Liarozole (1mg, intraperitoneally)orapyrase (1U/ear, grade
VII, Sigma-Aldrich, intradermally) was injected before RA treatment. Mice
received a mixture of ampicillin (1 g/L; Sigma-Aldrich), vancomycin (500 mg/L;
Shionogi), neomycin (1 g/L; Sigma-Aldrich), and metronidazole (1 g/ L; Sigma-
Aldrich) in drinking water since 2 weeks before RA treatment (Obata et al.,
2010). MCs were reconstituted in KitW-sh/W-sh mice by intraperitoneal and intra-
venous (53 106 cells each) or intradermal (13 106 cells) injection of BMMCs.
Cell Preparations
Mononuclear cells from the small intestine, colon, PEC, lung, and skinwere iso-
lated, and BMMCs were obtained as previously described (Kurashima et al.,
2012; Kurashima et al., 2007). To prepare stromal cells and fibroblasts, tissues
were digested with EDTA and collagenase (Sigma-Aldrich) and adherent cells
were passaged every 4 days (process repeated once). Before coculture with
BMMCs, cells were treated with 10 ng/ml mitomycin C (Sigma-Aldrich) for
3 hr and washed twice with PBS. In some experiments, BMMCs were
cytospinned (600 rpm, 4 min) and stained for 1 hr with alcian blue (Muto Pure
Chemicals, Tokyo, Japan) and for 20 min with safranin (Muto Pure Chemicals).
Inflammatory monocytes or macrophages were collected from PEC 3 days
after intraperitoneal injection of 2 ml of 4% thioglycolate.
In Vitro Treatment
ForMCP1 and TNF-ameasurement, 23 105 cells were stimulatedwith 0.5mM
of ATP for 2 days. For IL-1bmeasurement, 2 3 105 cells were stimulated with
0.1 mg/mL LPS for 8 hr, followed by 0, 0.5, or 5 mM of ATP for 1 hr. Chemokine
and cytokine production in the culture supernatant was measured with CBA
inflammatory cytokine kit (BD Biosciences) and IL-1b ELISA (R&D Systems).
To stimulate TLR2-mediated pathway, we cultured thioglycolate-induced
monocytes and macrophages with Pam2CSK4 (0.2 mg/mL, InvivoGen). To
measure ATP secretion from skin organ, we floated skin (8.0 mm square)
with the epidermis side upward on 12-well plates containing 1 ml PBS and
incubated on ice for 10 min. ATP concentration in the culture was measured
by ATP luciferase assay (PerkinElmer) (Kawamura et al., 2012; Kurashima
et al., 2012).
Flow Cytometry
Cells were incubated with 5 mg/ml of anti-CD16/32 antibody (Biolegend) for
5 min and then stained for 30 min at 4Cwith fluorescence-labeled antibodies;
c-kit (0.2 mg/mL), Gr-1 (0.4 mg/mL), CD4 (1 mg/mL), CD11b (0.2 mg/mL), CD11c
(0.4 mg/mL), and B220 (0.4 mg/mL) (BD Biosciences); FcεRIa (0.4 mg/mL)
and CD207 (0.4 mg/mL) (eBioscience); and F4/80 (20 mg/mL) and ER-TR7
(5 mg/mL) (Abcam), and P2X7 (2 mg/mL, clone 1F11) (Kurashima et al., 2012).
Flow cytometric analysis and cell sorting were performed with FACSCalibur
and FACSAria (BD Biosciences), respectively.
Histology and Scoring
Skin samples were fixed in 4% paraformaldehyde and embedded in paraffin.
Tissue sections (5 mm) were stained with hematoxylin and eosin (Wako). ToImmunity 40, 530–541, April 17, 2014 ª2014 Elsevier Inc. 539
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solution (Muto Pure Chemicals) for 1 hr and counterstained with toluidine blue
(Wako) for 20 min. For the staining with anti-mouse cathelicidin antibody
(Abcam), tissue sections were retrieved with Retrievagen A (BD Biosciences).
Inflammation severity was scored as follows: 0, no; 1, minimal; 2, mild; 3,
moderate; and 4, marked. The slides were blinded, randomized, and reread
to determine score. The total score was calculated as the sum of scores for
inflammation, neutrophil number, mononuclear cell number, edema, and
epithelial hyperplasia (Otsuka et al., 2011).
Whole-Mount FISH
Skin was fixed in 4% paraformaldehyde at 4C overnight and washed with
PBS for 7 hr. Tissues were hybridized with 10 mg/mL of Alexa 488-conjugated
DNA probe (EUB338, Invitrogen) in a hybridization buffer (0.9 M NaCl, 20 mM
Tris-HCl, 0.1% SDS, and 10 mg/mL) at 42C overnight. After washing twice in a
washing buffer (0.45 M NaCl, 20 mM Tris-HCl, 0.01% SDS) at 42C for 10 min,
tissues were flushed with PBS and observed by confocal microscopy (DM
IRE2/TCS SP2, Leica) (Obata et al., 2010).
Microarray Analysis
Total RNA was prepared with RNeasy kit (QIAGEN). cRNA was hybridized with
DNA probes on a GeneChip Mouse Genome 430 2.0 array (Affymetrix) (Kuni-
sawa et al., 2013). Data were analyzed with GeneSpring 7.3.1 software (Silicon
Genetics).
Quantitative RT-PCR
Total RNA was prepared with TRIzol (Invitrogen) and reverse transcribed by
Superscript VILO (Invitrogen). Quantitative RT-PCR was performed with the
LightCycler 480 II (Roche) and the Universal Probe Library (Roche). Primer
sequence is available in Table S1.
Statistical Analysis
Statistical analysis was performed with the unpaired two-tailed Student’s t test
and Welch’s t test. In some experiments, one-way ANOVA and Tukey’s
method were employed as indicated in figure legends.
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